Significant Ownership of Scilex Holding Co
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Scilex Holding Co focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Henry Ji - Henry Ji, CEO and President
- Manager location
- Palo Alto, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Scilex Holding Co with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Scilex Holding Co
Significant Ownership of Scilex Holding Co
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SMNRW | Semnur Pharmaceuticals, Inc. | Common Stock, par value $0.0001 | 79% | $1,815,201 | -$70,347 | 181,520,112 | -3.7% | Scilex Holding Company | 15 Jun 2026 |
| DVLT | DATAVAULT AI INC. | Common Stock, par value $0.0001 per share | 37% | $139,396,958 | -$10,411,129 | 213,766,229 | -6.9% | Scilex Holding Company | 12 Jan 2026 |
Schedules 13D/G Reported by Scilex Holding Co:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.